Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00699959 |
The purpose of this observational study is to compare frequency of attainment control goals through the more represented cardiovascular factor risk, dyslipidemia, among coronary patients with or without heart failure in cardiology consulting.
Condition |
---|
Coronary Patients Heart Failure |
Study Type: | Observational |
Study Design: | Cohort, Cross-Sectional |
Official Title: | Comparison and Description of Coronary Patients Management With or Without Heart Failure in Cardiology Consulting |
Estimated Enrollment: | 2000 |
Study Start Date: | June 2008 |
Study Completion Date: | February 2009 |
Groups/Cohorts |
---|
1
patients with heart failure
|
2
patients without heart failure
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
First two consecutive Coronary patients with or without heart failure
Inclusion Criteria:
Exclusion Criteria:
Study Director: | Alain Castaigne | AstraZeneca |
Responsible Party: | AstraZeneca Pharmaceuticals ( Alain Castaigne, Medical Director ) |
Study ID Numbers: | NIS-CFR-DUM-2007/8 |
Study First Received: | June 16, 2008 |
Last Updated: | April 14, 2009 |
ClinicalTrials.gov Identifier: | NCT00699959 History of Changes |
Health Authority: | France: French Data Protection Authority |
Coronary patients heart failure dyslipidemia |
Heart Failure Heart Diseases Dyslipidemias |
Heart Failure Heart Diseases Cardiovascular Diseases |